The History of Early Breast Cancer Treatment

被引：70

作者：

Ben-Dror, Judith ^{[1
]}

Shalamov, Michal ^{[2
]}

Sonnenblick, Amir ^{[1
,2
]}

机构：

[1] Tel Aviv Sourasky Med Ctr, IL-6423906 Tel Aviv, Israel

[2] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel

来源：

GENES | 2022年 / 13卷 / 06期

关键词：

breast cancer; molecular therapeutics; systemic treatment; targeted therapies; SURGICAL ADJUVANT BREAST; SENTINEL-NODE BIOPSY; NEOADJUVANT CHEMOTHERAPY; ENDOCRINE THERAPY; INTERNAL MAMMARY; RANDOMIZED-TRIAL; FOLLOW-UP; PREOPERATIVE CHEMOTHERAPY; AXILLARY DISSECTION; CONSERVING THERAPY;

D O I：

10.3390/genes13060960

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

"The story of cancer is the story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception" (Siddhartha Mukherjee). The present review discusses the evolution of early breast cancer (BC) treatment philosophy in the last 50 years and the shift from an emphasis on local therapy to an emphasis on systemic precision treatment options.

引用

页数：12

共 78 条

[1]

Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0

[2] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].

Albain, K. ;

Anderson, S. ;

Arriagada, R. ;

Barlow, W. ;

Bergh, J. ;

Bliss, J. ;

Buyse, M. ;

Cameron, D. ;

Carrasco, E. ;

Clarke, M. ;

Correa, C. ;

Coates, A. ;

Collins, R. ;

Costantino, J. ;

Cutter, D. ;

Cuzick, J. ;

Darby, S. ;

Davidson, N. ;

Davies, C. ;

Davies, K. ;

Delmestri, A. ;

Di Leo, A. ;

Dowsett, M. ;

Elphinstone, P. ;

Evans, V. ;

Ewertz, M. ;

Gelber, R. ;

Gettins, L. ;

Geyer, C. ;

Goldhirsch, A. ;

Godwin, J. ;

Gray, R. ;

Gregory, C. ;

Hayes, D. ;

Hill, C. ;

Ingle, J. ;

Jakesz, R. ;

James, S. ;

Kaufmann, M. ;

Kerr, A. ;

MacKinnon, E. ;

McGale, P. ;

McHugh, T. ;

Norton, L. ;

Ohashi, Y. ;

Paik, S. ;

Pan, H. C. ;

Perez, E. ;

Peto, R. ;

Piccart, M. .

LANCET, 2012, 379 (9814) :432-444

[3] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer [J].

Andre, Fabrice ;

Ciruelos, Eva ;

Rubovszky, Gabor ;

Campone, Mario ;

Loibl, Sibylle ;

Rugo, Hope S. ;

Iwata, Hiroji ;

Conte, Pierfranco ;

Mayer, Ingrid A. ;

Kaufman, Bella ;

Yamashita, Toshinari ;

Lu, Yen-Shen ;

Inoue, Kenichi ;

Takahashi, Masato ;

Papai, Zsuzsanna ;

Longin, Anne-Sophie ;

Mills, David ;

Wilke, Celine ;

Hirawat, Samit ;

Juric, Dejan .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1929-1940

[4]

[Anonymous], USE LETROZOLE AROMAT

[5]

[Anonymous], 2013, J CLIN ONCOL, V31, P5, DOI 10.1200/jco.2013.31.18_suppl.5

[6] Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study [J].

Bachelot, Thomas ;

Bourgier, Celine ;

Cropet, Claire ;

Ray-Coquard, Isabelle ;

Ferrero, Jean-Marc ;

Freyer, Gilles ;

Abadie-Lacourtoisie, Sophie ;

Eymard, Jean-Christophe ;

Debled, Marc ;

Spaeth, Dominique ;

Legouffe, Eric ;

Allouache, Djelila ;

El Kouri, Claude ;

Pujade-Lauraine, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (22) :2718-2724

[7] Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer [J].

Bardia, A. ;

Hurvitz, S. A. ;

Tolaney, S. M. ;

Loirat, D. ;

Punie, K. ;

Oliveira, M. ;

Brufsky, A. ;

Sardesai, S. D. ;

Kalinsky, K. ;

Zelnak, A. B. ;

Weaver, R. ;

Traina, T. ;

Dalenc, F. ;

Aftimos, P. ;

Lynce, F. ;

Diab, S. ;

Cortes, J. ;

O'Shaughnessy, J. ;

Dieras, V ;

Ferrario, C. ;

Schmid, P. ;

Carey, L. A. ;

Gianni, L. ;

Piccart, M. J. ;

Loibl, S. ;

Goldenberg, D. M. ;

Hong, Q. ;

Olivo, M. S. ;

Itri, L. M. ;

Rugo, H. S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16) :1529-1541

[8] Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer [J].

Bardia, Aditya ;

Mayer, Ingrid A. ;

Diamond, Jennifer R. ;

Moroose, Rebecca L. ;

Isakoff, Steven J. ;

Starodub, Alexander N. ;

Shah, Nikita C. ;

O'Shaughnessy, Joyce ;

Kalinsky, Kevin ;

Guarino, Michael ;

Abramson, Vandana ;

Juric, Dejan ;

Tolaney, Sara M. ;

Berlin, Jordan ;

Messersmith, Wells A. ;

Ocean, Allyson J. ;

Wegener, William A. ;

Maliakal, Pius ;

Sharkey, Robert M. ;

Govindan, Serengulam V. ;

Goldenberg, David M. ;

Vahdat, Linda T. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2141-+

[9] Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer [J].

Blum, JL ;

Jones, SE ;

Buzdar, AU ;

LoRusso, PM ;

Kuter, I ;

Vogel, C ;

Osterwalder, B ;

Burger, HU ;

Brown, CS ;

Griffin, T .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :485-493

[10] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].

BONADONNA, G ;

BRUSAMOLINO, E ;

VALAGUSSA, P ;

ROSSI, A ;

BRUGNATELLI, L ;

BRAMBILLA, C ;

DELENA, M ;

TANCINI, G ;

BAJETTA, E ;

MUSUMECI, R ;

VERONESI, U .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410

← 1 2 3 4 5 6 7 8 →